LIFTT invests in Keyron’s anti-diabetes and obesity device Your browser does not seem to support iframes. Click here to read this PDF.Your browser does not seem to support iframes. Click here to read this PDF. Created using FlowPaper Flipbook Maker ↗ LIFTT Venture Capital Italia2022-12-29T15:51:22+01:0022 December 2021| Share FacebookXLinkedInWhatsAppEmail